Login
 Forum
 
 
Personal data sheet
 Print preview
personal data approved: 2014. VI. 27.
Personal data
Zsuzsanna Kahán
name Zsuzsanna Kahán
year of birth 1953
name of institution
University of Szeged
Habilitation Committee of the University
doctoral school
SzTE Doctoral School of Interdisciplinary Medicine (Core member)
(discipline) Habilitation Comittee (chairman)
doktori képzéssel kapcsolatos munkájának megoszlása SzTE Doctoral School of Interdisciplinary Medicine 98%
SzTE IDS-SzTE (discipline) Habilitation Comittee (chairman) 1%
SzTE Habilitation Committee of the University 1%
accreditation statement submitted to: University of Szeged
Contact details
E-mail address kahanonko.szote.u-szeged.hu
phone number +36 62 545-404
own web page
Academic title
scientific degree, title Ph.D.
year degree was obtained 1996
discipline to which degree belongs clinical medicine
institution granting the degree Szent-Györgyi Albert Medical University
scientific degree, title DSc
year degree was obtained 2013
discipline to which degree belongs clinical medicine
institution granting the degree HAS
Places of employment
1998 - Szegedi Tudományegyetem Onkoterápiás Klinika
1998 - University of Szeged
university professor or researcher
Thesis topic supervisor
number of doctoral students supervised until now 4
number of students who fulfilled course requirements 0
students who obtained their degrees:
Gyöngyi Kelemen PhD 2012  IDS-SzTE
Alíz Nikolényi PhD 2011  IDS-SzTE
Zoltán Varga PhD 2010  IDS-SzTE

students with degree granting in process:
Éva Szilágyi PhD (2014/12)  IDS-SzTE
Laura Kiscsatári PhD (2015/12)  IDS-SzTE
Orsolya Rusz PhD (2014/12)  
Tamás Müller PhD (2015/12)  IDS-SzTE
  Thesis topic proposals
Research
research area Breast cancer - experimental and clinical (chemotherapy and radiotherapy)
research field in which current research is conducted theoretical medicine
clinical medicine
Publications
2013

Zoltán Varga, Adrienn Cserháti, Ferenc Rárosi, Krisztina Boda, Gergely Gulyás, Zsófia Együd, Zsuzsanna Kahán: Individualized positioning for maximum heart protection during breast irradiation, ACTA ONCOLOGICA 52: pp. 1-7.
type of document: Journal paper/Article
impact factor: 2.867*
language: English
Full text of document 
2012

Lang I, Inbar M J, Kahan Z, Greil R, Beslija S, Stemmer S M, Kaufman B, Zvirbule Z, Steger G G, Messinger D, Brodowicz T, Zielinski C: Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer, EUROPEAN JOURNAL OF CANCER 48: (17) pp. 3140-3149.
type of document: Journal paper/Article
impact factor: 5.061
language: English
Full text of document 
2011

Varga Z, Cserhati A, Kelemen G, Boda K, Thurzo L, Kahan Z: The role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 80: (4) pp. 1109-1116.
type of document: Journal paper/Article
impact factor: 4.105
number of independent citations: 2
language: English
Full text of document 
2010

Pritchard KI, Rolski J, Papai Z, Mauriac L, Cardoso F, Chang J, Panasci L, Ianuli C, Kahan Z, Fukase K, Lindemann JPO, Macpherson MP, Neven P: Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2), BREAST CANCER RESEARCH AND TREATMENT 123: (2) pp. 453-461.
type of document: Journal paper/Article
impact factor: 4.859
number of independent citations: 19
language: English
Full text of document 
2009

Varga Z, Hideghety K, Mezo T, Nikolenyi A, Thurzo L, Kahan Z: Individual positioning: a comparative study of adjuvant breast radiotherapy in the prone versus supine position., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75: (1) pp. 94-100.
type of document: Journal paper/Article
impact factor: 4.592
number of independent citations: 11
language: English
Full text of document 
2007

Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A, Gyulai Z, Mandi Y, Boda K, Thurzo L: The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 68: (3) pp. 673-681.
type of document: Journal paper/Article
impact factor: 4.290
number of independent citations: 31
language: English
Full text of document 
2000

Kahan Z, Varga JL, Schally AV, Rekasi Z, Armatis P, Chatzistamou L, Czompoly T, Halmos G: Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice., BREAST CANCER RESEARCH AND TREATMENT 60: pp. 71-79.
type of document: Journal paper/Article
impact factor: 2.720
number of independent citations: 13
language: English
Full text of document 
1999

Kahan Z, Nagy A, Schally AV, Halmos G, Arencibia JM, Groot K: Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207, CANCER 85: (12) pp. 2608-2615.
type of document: Journal paper/Article
impact factor: 3.632
number of independent citations: 5
language: English
Full text of document 
1999

Kahan Z, Arencibia JM, Csernus VJ, Groot K, Kineman RD, Robinson WR, Schally AV: Expression of growth hormone-releasing hormone (GHRH) messengerribonucleic acid and the presence of biologically active GHRH in humanbreast, endometrial, and ovarian cancers, JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 84: (2) pp. 582-589.
type of document: Journal paper/Article
impact factor: 5.805
number of independent citations: 27
language: English
Full text of document 
1998

Nagy A, Schally AV, Halmos G, Armatis P, Cai RZ, Csernus V, Kovacs M, Koppan M, Szepeshazi K, Kahan Z: Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 95: (4) pp. 1794-1799.
type of document: Journal paper/Article
impact factor: 9.821
number of independent citations: 63
language: English
Full text of document 
Cumulative impact factor of the 10 most significant publications:44.885 
Number of independent citations to these publications:171 
Scientometric data
list of publications and citations
number of scientific publications that meet accreditation criteria:
95
number of scientific publications:
208
monographs and professional books:
2
no. of monographs/books in which chapters/sections were contributed:
3 
no. of art/engineering projects:
0
cumulative impact factor:
119.334
scientific publications published abroad that meet the accreditation criteria:
42
publications not in Hungarian, published in Hungary, meeting the accreditation criteria:
12
number of independent citations to scientific publications:
352


2014. X. 22.
ODT ülés
Az ODT következő ülésére 2014. november 14-én kerül sor a Semmelweis Egyetem Szenátusi termében (Bp. Üllői út 26. I. emelet).

 
All rights reserved © 2007, Hungarian Doctoral Council. Doctoral Council registration number at commissioner for data protection: 02003/0001. Program version: 1.1517 ( 2014. X. 22. )